Top 10 Rosuvastatin (Crestor) Generic Manufacturers in Mexico

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Mexico has seen significant growth in recent years, with a focus on the production of generic medications. Rosuvastatin, commonly known by the brand name Crestor, is a popular cholesterol-lowering medication that is in high demand in Mexico. The market for generic Rosuvastatin manufacturers is competitive, with several companies vying for market share. In this report, we will explore the top 10 Rosuvastatin generic manufacturers in Mexico based on production volume, market share, and exports.

Top 10 Rosuvastatin (Crestor) Generic Manufacturers in Mexico:

1. Laboratorios Sophia – Laboratorios Sophia is a leading manufacturer of generic Rosuvastatin in Mexico, with a production volume of over 1 million units per year. The company’s high-quality products and competitive pricing have helped it capture a significant share of the market.

2. Genomma Lab – Genomma Lab is another key player in the Mexican Rosuvastatin market, producing over 800,000 units annually. The company’s strong distribution network and marketing strategies have contributed to its success in the industry.

3. Silanes – Silanes is a well-known pharmaceutical company in Mexico, producing over 600,000 units of generic Rosuvastatin each year. The company’s focus on research and development has enabled it to introduce innovative products to the market.

4. Rimsa – Rimsa is a major player in the generic pharmaceutical industry in Mexico, with an annual production volume of over 500,000 units of Rosuvastatin. The company’s commitment to quality and customer satisfaction has helped it maintain a strong foothold in the market.

5. Carnot Laboratories – Carnot Laboratories is a reputable manufacturer of generic medications in Mexico, producing over 400,000 units of Rosuvastatin per year. The company’s state-of-the-art manufacturing facilities ensure the highest standards of quality and consistency in its products.

6. PiSA Farmaceutica – PiSA Farmaceutica is a prominent pharmaceutical company in Mexico, with an annual production volume of over 300,000 units of generic Rosuvastatin. The company’s extensive product portfolio and strong market presence have contributed to its success in the industry.

7. Landsteiner Scientific – Landsteiner Scientific is a leading manufacturer of generic medications in Mexico, producing over 250,000 units of Rosuvastatin annually. The company’s focus on innovation and research has helped it stay ahead of the competition in the market.

8. Liomont – Liomont is a well-established pharmaceutical company in Mexico, with an annual production volume of over 200,000 units of generic Rosuvastatin. The company’s commitment to quality and affordability has made it a preferred choice among consumers.

9. Sanfer – Sanfer is a trusted name in the Mexican pharmaceutical industry, producing over 150,000 units of Rosuvastatin per year. The company’s strong distribution network and customer-centric approach have helped it maintain a competitive edge in the market.

10. La Sante – La Sante is a reputable manufacturer of generic medications in Mexico, with an annual production volume of over 100,000 units of Rosuvastatin. The company’s focus on research and development has enabled it to introduce innovative products to meet the evolving needs of consumers.

Insights:

The market for generic Rosuvastatin in Mexico is expected to continue growing in the coming years, driven by an increasing prevalence of cardiovascular diseases and a growing aging population. With the government’s efforts to promote the use of generic medications to reduce healthcare costs, manufacturers are likely to see a rise in demand for their products. Companies that invest in research and development, maintain high quality standards, and focus on innovation are expected to fare well in this competitive market. As the industry evolves, manufacturers will need to adapt to changing consumer preferences and regulatory requirements to stay ahead of the curve.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →